JP2008536930A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536930A5
JP2008536930A5 JP2008507782A JP2008507782A JP2008536930A5 JP 2008536930 A5 JP2008536930 A5 JP 2008536930A5 JP 2008507782 A JP2008507782 A JP 2008507782A JP 2008507782 A JP2008507782 A JP 2008507782A JP 2008536930 A5 JP2008536930 A5 JP 2008536930A5
Authority
JP
Japan
Prior art keywords
cells
cell
composition
relatively pure
ischemic tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008507782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536930A (ja
JP4659092B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/014445 external-priority patent/WO2006113647A2/en
Publication of JP2008536930A publication Critical patent/JP2008536930A/ja
Publication of JP2008536930A5 publication Critical patent/JP2008536930A5/ja
Application granted granted Critical
Publication of JP4659092B2 publication Critical patent/JP4659092B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008507782A 2005-04-18 2006-04-18 損傷組織へのb細胞投与による組織機能の回復 Expired - Lifetime JP4659092B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67241605P 2005-04-18 2005-04-18
PCT/US2006/014445 WO2006113647A2 (en) 2005-04-18 2006-04-18 Recovery of tissue function following administration of b cells to injured tissue

Publications (3)

Publication Number Publication Date
JP2008536930A JP2008536930A (ja) 2008-09-11
JP2008536930A5 true JP2008536930A5 (cg-RX-API-DMAC7.html) 2010-07-15
JP4659092B2 JP4659092B2 (ja) 2011-03-30

Family

ID=37115830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008507782A Expired - Lifetime JP4659092B2 (ja) 2005-04-18 2006-04-18 損傷組織へのb細胞投与による組織機能の回復

Country Status (5)

Country Link
US (2) US7695712B2 (cg-RX-API-DMAC7.html)
EP (1) EP1877544B1 (cg-RX-API-DMAC7.html)
JP (1) JP4659092B2 (cg-RX-API-DMAC7.html)
AT (1) ATE537249T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006113647A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4659092B2 (ja) * 2005-04-18 2011-03-30 エーシーティーエックス,インコーポレイテッド 損傷組織へのb細胞投与による組織機能の回復
US9220813B2 (en) * 2005-04-18 2015-12-29 Holy Cross Hospital, Inc. Cell therapy for limiting overzealous inflammatory reactions in tissue healing
WO2008103336A1 (en) * 2007-02-21 2008-08-28 Cook Incorporated Methods for intravascular engraftment in heart
KR101922118B1 (ko) 2012-08-27 2018-11-26 삼성전자주식회사 플렉서블 반도체소자 및 그 제조방법
EP2943206A4 (en) 2013-01-12 2017-01-04 Cesca Therapeutics Inc. Rapid infusion of autologous bone marrow derived stem cells
WO2015066076A1 (en) 2013-10-28 2015-05-07 Biocardia, Inc. Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
US9775816B2 (en) 2013-11-07 2017-10-03 The General Hospital Corporation Eluting matrix and uses thereof
CN113677354A (zh) * 2019-01-23 2021-11-19 综合医院公司 B细胞免疫疗法
WO2021211997A1 (en) * 2020-04-16 2021-10-21 The General Hospital Corporation B cell immunomodulatory therapy for acute respiratory distress syndrome
WO2022094284A1 (en) * 2020-10-30 2022-05-05 Immusoft Corporation Methods of administering genetically modified b cells for in vivo delivery of therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US6465251B1 (en) * 1996-11-13 2002-10-15 Dana-Farber Cancer Institute, Inc. Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
CA2505924A1 (en) 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
JP4659092B2 (ja) * 2005-04-18 2011-03-30 エーシーティーエックス,インコーポレイテッド 損傷組織へのb細胞投与による組織機能の回復

Similar Documents

Publication Publication Date Title
Dan et al. The influence of cellular source on periodontal regeneration using calcium phosphate coated polycaprolactone scaffold supported cell sheets
RU2009100930A (ru) Лекарственные средства для стимуляции роста гемопоэтических стволовых клеток
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
DE69941903D1 (de) Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern
JP2002506831A5 (cg-RX-API-DMAC7.html)
JP2002531193A (ja) 生きた組織を再生するための方法および物品
WO2004009767A3 (en) Cell therapy for regeneration
JP2013515497A5 (cg-RX-API-DMAC7.html)
Khademi et al. Periodontal healing of replanted dog teeth stored in milk and egg albumen
JP2010518946A5 (cg-RX-API-DMAC7.html)
RU2003137823A (ru) Каркасы для инженерии костной ткани человека, способы их изготовления и их применение
CN102470034A (zh) 齿槽骨移植材料的加工方法及由其制备的齿槽骨移植材料和利用上述齿槽骨移植材料的治疗方法
JP2002524421A5 (cg-RX-API-DMAC7.html)
Manimaran et al. Regeneration of mandibular ameloblastoma defect with the help of autologous dental pulp stem cells and buccal pad of fat stromal vascular fraction
Chen et al. Cranioplasty using allogeneic perforated demineralized bone matrix with autogenous bone paste
RU2008152746A (ru) Лечение ишемических заболеваний с применением эритропоэтина
AR085141A1 (es) Un metodo para prolongar la supervivencia de un aloinjerto renal, uso de un anticuerpo anti-cd200 para prolongar la supervivencia de aloinjertos
Ohba et al. Onlay bone augmentation on mouse calvarial bone using a hydroxyapatite/collagen composite material with total blood or platelet-rich plasma
JP2005517404A5 (cg-RX-API-DMAC7.html)
Artzi et al. Simultaneous versus two‐stage implant placement and guided bone regeneration in the canine: histomorphometry at 8 and 16 months
JP2016524989A5 (cg-RX-API-DMAC7.html)
RU2545993C2 (ru) Способ восстановления костных дефектов трубчатых костей критической величины
Ogawa et al. Xenotransplantation of cryopreserved human clumps of mesenchymal stem cells/extracellular matrix complexes pretreated with IFN-γ induces rat calvarial bone regeneration
WO2003059375A1 (en) Complex therapy for tissue regeneration
CN203609545U (zh) 髁突假体